Clinical Trials Directory

Trials / Completed

CompletedNCT01069172

Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Capsulorhexis for Cataract Surgery

A Prospective, Randomized Study of Cataract Surgery With the Assistance of the OptiMedica Femtosecond Laser System Compared to Standard Surgical Procedure of Continuous Curvilinear Capsulorhexis and Ultrasonic Phacoemulsification

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Abbott Medical Optics · Industry
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of the OptiMedica Femtosecond Laser System to perform surgical maneuvers used in the treatment of subjects with cataracts. The safety and efficacy will be compared to the standard surgical procedure of continuous curvilinear capsulorhexis (CCC) and ultrasonic phacoemulsification.

Conditions

Interventions

TypeNameDescription
DEVICEFS Laser SurgeryThe Catalys System is an ophthalmic surgical laser system intended for use in cataract surgery to perform capsulotomy, lens segmentation, and lens softening, which are all part of cataract surgery when this femtosecond laser is used.
PROCEDURECCC SurgerySubjects will receive the standard of care for CCC and U/S cataract surgery to facilitate removal of the crystalline lens. CCC is a procedure that is part of cataract surgery.

Timeline

Start date
2010-02-01
Primary completion
2010-07-01
Completion
2010-08-01
First posted
2010-02-17
Last updated
2014-09-04
Results posted
2014-09-04

Locations

1 site across 1 country: Dominican Republic

Source: ClinicalTrials.gov record NCT01069172. Inclusion in this directory is not an endorsement.